Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025
Elevance Health (NYSE: ELV) will release fourth quarter and full year 2024 financial results on January 23, 2025, at 6:00 a.m. Eastern Standard Time ("EST"). Management will review these results and its outlook during a conference call at 8:30 a.m. EST that same morning. The conference call should be accessed at least 15 minutes prior to its start with the following numbers:
203-369-0604 ? No Access Code (International Replay)
The replay will be available from 11:30 a.m. EST on January 23, 2025, until the end of the day on February 21, 2025. The call will also be available through a live webcast at www.elevancehealth.com under the "Investors" link. You may also access the webcast here. A webcast replay will be available following the call.
About Elevance Health
Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey ? connecting them to the care, support, and resources they need to lead better lives. Elevance Health's companies serve approximately 113 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.
Vertical Bridge REIT, LLC ("Vertical Bridge" or "the Company"), the largest private owner and operator of communications infrastructure in the United States, today announced that Vertical Bridge Charitable Network ("VBCN") surpassed $14 million in...
CIBC released today an abridged Supplementary Financial Information package for the fiscal years ending October 31, 2024 and 2023, reflecting the following changes that were effective November 1, 2024:...
Kress, the leading innovator in battery-powered, professional landscaping equipment and robotics, has been approved by Sourcewell, the Minnesota-based government organization that provides cooperative purchasing nationwide. The new cooperative...
111 Equity is very encouraged by this transaction and looks forward to more information on the transaction being released to the market soon. The CEAD board and CEO Tony McDonald are proving to be great stewards of the company's resources in securing...
Olympus Partners has acquired PAI Pharma ("PAI"), the leading developer, manufacturer and distributor of generic oral liquids in both ready-to-dose cups and bottles in the United States. PAI offers the broadest portfolio of generic oral liquid...
Picton Mahoney Asset Management announced today that it has declared the February 2025 monthly cash distribution of $0.0284 per unit for the ETF units ("ETF Units") of the Picton Mahoney Fortified Income Alternative Fund. Picton Mahoney Asset...